Vox Markets Daily
7th November 2019
Jonathan Tobin, Investment Director, speaks to Vox Markets about our portfolio companies Artios Pharma which has announced the expansion of its DNA Damage Response pipeline with a new asset.
Stay Updated
Add your email below to stay updated with useful and informative content from Arix and our portfolio companies